替米沙坦與代謝綜合征

替米沙坦與代謝綜合征

ID:39725330

大?。?.22 MB

頁(yè)數(shù):69頁(yè)

時(shí)間:2019-07-10

替米沙坦與代謝綜合征_第1頁(yè)
替米沙坦與代謝綜合征_第2頁(yè)
替米沙坦與代謝綜合征_第3頁(yè)
替米沙坦與代謝綜合征_第4頁(yè)
替米沙坦與代謝綜合征_第5頁(yè)
資源描述:

《替米沙坦與代謝綜合征》由會(huì)員上傳分享,免費(fèi)在線閱讀,更多相關(guān)內(nèi)容在教育資源-天天文庫(kù)。

1、WillaHsueh,M.D.ProfessorofMedicine Chief,DivisionofEndocrinology,Diabetes,andHypertensionUCLADavidGeffenSchoolofMedicineLosAngeles,CaliforniaCardiovascularRiskContinuum:ImplicationsofInsulinResistanceandDiabetesDiabetesisavasculardisease:AngiotensinIIhasbeenimplicatedinboththede

2、velopmentofdiabetesanditscomplicationsDiabetes?Insulin-mediatedglucoseuptakeSkeletalmuscleAdipose?FFA?InflammatoryAdipokinesLiver?GlucoseproductionPancreas?InsulinproductionAtherosclerosisCAD,?Stroke,?PeripheralvasculardiseaseDiabeticNephropathy?AlbuminexcretionDiabeticRetinopat

3、hy?VEGF??neovascularizationDiastolicdysfunction,interstitialfibrosis?heartfailureCardiomyopathy?????????IL6PAI-1TNF?adiponectinleptinInsulinsensitivityinsulinresistanceVascularinflammationendothelialdysfunctionangiotensinogenFFAAdipocyteAdipokinesMediateInsulinResistanceandInfla

4、mmationProgressionofAtherosclerosisinInsulinResistanceEndothelialDysfunctionTG,HDL-CsdLDL-CHypertensionUricAcidPAI-1InflammationThrombosisOxidationAtherosclerosisAtherosclerosisUnstableplaqueInflammation,FibrosisCapThrombosisandRuptureEventHyperinsulinemiaMetabolicSyndromeImpair

5、edGlucoseToleraneType2DiabetesHsuehWA,LawR.AJC,2003InsulinResistanceForindividualsbornin2000:Males–32.8%Females–38.5%Estimatedlossoflifeexpectancyifdiagnosedatage40:Males–11.6yearsFemales–14.3yearsNarayanJAMA2003LifetimeRiskforDiabetesintheUS13NH313NH313NH3Dipyridamole(0.56mg/kg

6、)135’RestQuinonesetalAnnInternMed.,2004;140:700-8NoninvasiveMeasurementsof MyocardialBloodFlow:PositronEmissionTomography0’25’45’70’90’115’CPTDIPApproachesthatImproveCoronaryVasomotorFunctioninInsulinResistance:Insulinsensitizers:TZDs,PPAR?ligandsAT1receptorblockers:ARBsGlucosec

7、ontrolintype2diabetes:MetforminVALUE(ValsartanAntihypertensiveLong-TermUseEvaluation):23%lessnewonsetdiabeteswithvalsartancomparedtoamlodipineinpatientswithhypertensionHOPE(HeartOutcomesPreventionEvaluation):32%lessnewonsetdiabeteswithramiprilcomparedtoplaceboinhighcardiovascula

8、rriskpatientsLIFE(LosartanInterventionforEndpoi

當(dāng)前文檔最多預(yù)覽五頁(yè),下載文檔查看全文

此文檔下載收益歸作者所有

當(dāng)前文檔最多預(yù)覽五頁(yè),下載文檔查看全文
溫馨提示:
1. 部分包含數(shù)學(xué)公式或PPT動(dòng)畫(huà)的文件,查看預(yù)覽時(shí)可能會(huì)顯示錯(cuò)亂或異常,文件下載后無(wú)此問(wèn)題,請(qǐng)放心下載。
2. 本文檔由用戶上傳,版權(quán)歸屬用戶,天天文庫(kù)負(fù)責(zé)整理代發(fā)布。如果您對(duì)本文檔版權(quán)有爭(zhēng)議請(qǐng)及時(shí)聯(lián)系客服。
3. 下載前請(qǐng)仔細(xì)閱讀文檔內(nèi)容,確認(rèn)文檔內(nèi)容符合您的需求后進(jìn)行下載,若出現(xiàn)內(nèi)容與標(biāo)題不符可向本站投訴處理。
4. 下載文檔時(shí)可能由于網(wǎng)絡(luò)波動(dòng)等原因無(wú)法下載或下載錯(cuò)誤,付費(fèi)完成后未能成功下載的用戶請(qǐng)聯(lián)系客服處理。